Publications
Chosen filters:
Chosen filters:
Challenges and opportunities of U+2018good governanceU+2019 for drug policy : the case of the development of Belgian drug policy between 1996 and 2003 Ghent University
How to evaluate complex drug policies? A case study of the Belgian drug policy Ghent University
Evaluation is widely considered an essential part of drug policy. Nevertheless, evaluators are often confronted with methodological and theoretical challenges, especially when dealing with complex policy initiatives like a national drug policy. After all, drug policies are characterized by high degrees of uncertainty and emergence, but also by gradual adaptation and dynamical patterns, bringing high levels of unpredictability. To match the ...
A retrospective and prospective assessment of the zero-markup drug reform in China from the perspective of policy diffusion Vrije Universiteit Brussel
The zero-markup drug policy is an important component of the new round of Chinese health care reform that began in 2009 to promote the separation between medical and pharmaceutical services, reduce patients' medical burden, and improve the medical supply security system. Over the past 8 years, the zero-markup drug reform policy has been carried out in 4 pilot rounds (a policy diffusion model with Chinese characteristics) and has been promoted ...
How to overcome political and legal barriers to the implementation of a drug consumption room : an application of the policy agenda framework to the Belgian situation Ghent University
Background: For more than 30 years, drug consumption rooms (DCRs) have been implemented in Western countries. DCRs are supported by a large body of evidence about public safety and public health effectiveness. However, a political consensus has never been achieved in Belgium on amending the existing law that explicitly penalises the supply of a room for facilitating drug use. Despite this adverse legal and policy framework, a DCR opened in the ...